MorphoSys Announces that its Licensee Janssen has Expanded Clinical Development of Guselkumab TremfyaR into Familial Adenomatous Polyposis news with additional features

DGAPNews MorphoSys AG Key words Study15.04.2019 2201 The issuer is solely responsible for the content of this announcement.PlaneggMunich Germany April 15 2019MorphoSys Announces that its Licensee Janssen has Expanded Clinical Development of Guselkumab Tr...